Another Alzheimer’s drug fails in late-stage trials – what now?
Another Alzheimer’s drug fails in late-stage trials – what now?: Atthapon Raksthaput/Shutterstock Around 55 million people, globally, have dementia – the most common type being Alzheimer’s disease. Unfortunately, there is no cure for the memory-robbing disease. But a lot of hope was pinned on an experimental drug called gantenerumab. A press release, recently issued by …
